Metabolic syndrome prevalence is increased with increasing thyroid hormone resistance levels among normothyroid subjects
Congress:
86th Congress of the European Atherosclerosis Society
Participation type:
Comunicación oral
Other authors:
M. Laclaustra , B. Moreno-Franco , R. Mateo-Gallego , S. Perez-Calahorra , I. Lamiquiz-Moneo , V. Marco-Benedi , A. Cenarro , J.A. Casasnovas , F. Civeira
Year:
2018
Location:
Lisbon, Portugal
Publication:
M. Laclaustra, B. Moreno-Franco, R. Mateo-Gallego, S. Perez-Calahorra, I. Lamiquiz-Moneo, V. Marco-Benedi, A. Cenarro, J.A. Casasnovas, F. Civeira. Metabolic syndrome prevalence is increased with increasing thyroid hormone resistance levels among normothyroid subjects. Atherosclerosis 275 (2018) e18
URL:
https://doi.org/10.1016/j.atherosclerosis.2018.06.038